{"ticker": {"uuid": "2a25fcdb-951e-4695-ac2e-c22b3d508cde", "symbol": "PCRX", "name": "Pacira BioSciences, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Pacira BioSciences stock trades steady as pain-management pipeline stays in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOTTVtb25fTjdNbXBvY0hIdUZBZXZUV0djTUlBazJkcXRxVU5tOGl0YndJWDlQNVlsNjNDSWplTzZ5cU9VQ1lKVkFYMlZkOWlWVTRTNGZVblowYTlIQi1LS0hPellyMXRYWVNPUTIydVQzNWJ6Q3NzYUlTejBndVp4S2UxWlYwRndBTXkxOEJkX09iejJZNWhjVjJvdERxcEJmLUlnVXlPdVY0Rl83MW1JM3ZFOU5PR3NHb1NROVkxeFdyN3piXzdOamJQYw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T14:45:35+00:00", "published_display": "09 Jul 2026 14:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences (PCRX) Wins Broader EXPAREL Reimbursement, Is The Stock Still Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQQXlrZHlDMU1LaWFQMEY2bUFVY21CbF9CR09USDRISGY1ajdQM241UGdIbjV4N2FmRjZyR0N6UDg3aURlSnE2ckp1bFdvN0VVSjhON2w3ekpjRzhxel81N010d3JtMlExTzJWd1NFUXpOcDVTUjlDVE9tMUJ6ZFBuT19fSXNpek5hOUtfVUNtSTZDUkhnUWdFYXIzSVR0M2pfTy1pNENLWTlHZTVmb0t5U0RBeVJyRDQxaVVyTzhHWFd2WE5feEl1WGY5SzdMUDktVFVZTWg1YUlaMnIyWDZCYThLdVE1ZknSAewBQVVfeXFMUGZ5VE1wWVp4bGY4YU9CenVYR2xHTjlSdUp4RnhKSXRIR05pcnRCZHFmWWh5OU5LUEpVV0x1MWFHYm1lWU44R0o4UWMzbF9xUFZWemo3dHgwMXVYcEotTnRMdmYtYlFXZ2RsczNYVVExYmVBclBaUHJYLXkzS0FNVzNITW9KTzBfaTJuWEZNQVcwelFEMjRIdnk0MFVjcjRPWHdkR08tZzM5c0ZKWkMtMTAzYk1vR0J3c0VoU3VWbjY2WUZram5fV1JDNU1RbXZueEM2SkdMTGt6RUVXYk02Y3dNci1SejRlcEJNbGI?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T12:40:09+00:00", "published_display": "08 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQTDZVbjY3ZV93VncyaTFFaWl5QUZfNm9MQlVya3RNV3FuRmFPRW5FSnlmbWwzbUxyYlU0VURiaFZ5OHZhNEcwQ1pIMmFpeFk0QzJsMVA3TmtadTZVR04xTXo2aDNwRXl6RTkta0hKcmJjZUktaUwyLXkzNmF2dlFlS1NxRGd1SERDejJwbXVEUXlCMVZWVjY3dzg0RmNZY2JlOFI4blF4aUtEcm9felgyaXhtZDlXRERYNVpQMFBqWE5sRGhfaDdMM1dMUDQxbWRmY3F4NQ?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-08T12:24:19+00:00", "published_display": "08 Jul 2026 12:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Pacira BioSciences (PCRX) Winning Broader EXPAREL Reimbursement From UnitedHealthcare", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T09:29:11+00:00", "published_display": "07 Jul 2026 09:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zimmer Biomet (ZBH) Is Buying Pacira\u2019s Iovera Device And Expanding Into Spasticity", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/zimmer-biomet-zbh-buying-pacira-042943339.html", "source_name": "Simply Wall St.", "published_at": "2026-07-02T04:29:43+00:00", "published_display": "02 Jul 2026 04:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences' Exparel Now Separately Reimbursed by UnitedHealthcare Across Outpatient Settings", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pacira-biosciences-apos-exparel-now-125344211.html", "source_name": "MT Newswires", "published_at": "2026-07-01T12:53:44+00:00", "published_display": "01 Jul 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL\u00ae", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pacira-biosciences-announces-unitedhealthcare-now-120000445.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T12:00:00+00:00", "published_display": "01 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zimmer Biomet to acquire iovera device from Pacira for $140m", "summary": "", "url": "https://finance.yahoo.com/m/cf358e7c-fe12-3fab-8333-794fb9d94115/zimmer-biomet-to-acquire.html", "source_name": "Medical Device Network", "published_at": "2026-07-01T10:53:42+00:00", "published_display": "01 Jul 2026 10:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealthcare opens separate reimbursement for Pacira's EXPAREL", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNaUlIYzlSdFAzcUlSNUZUS1UtTzVTOEE1VFVXNTVRWlR2dmpNQkRNNEtobm80TXhPNkFyalo0OVozNWVQekV1U3BSQ0EwYWotQzA3N3JNWTYxZU03eDFOMC1WZmdSb3pCSUJyY2hhc0Z0RXctcGZEbXpGaDdHaFMzTWw3dlVkMFhENXZYLWctSmxPTDZaY1BRR2VOWC1UZDc1MGRvRzlybGdxQk84ZWVObkpYY3FPZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Divests CryoTech to Zimmer Biomet", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPUEdRblJzUzRSMUt5YXVMNnllelV2VTJZeGs1dDhxYk5HVUNpbTA4MHg4YWQ3aVBra0tlZWxFWkh0ZjJBdWpHOVptRlRobGFKMTVHQU9ZTVVhY1B1cTZXQm80al82ZlB6V3FzZmlaSlBXakdJcFRkbU1tMlhTbkh5VXNJVnM5Z1czQ2p3MkhGTnZKU3lnTG5XRlBmN3RnZXozZC1oblo4bzQ3N2pfWDlPOEt6b01iVG5KNE52NDdjYmduZV91czFZZm53MlFsbzQwM0NZVWtn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira offloads iovera\u00b0 for up to $140M, keeps spasticity program", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOQnRzWGsxcndydGtHOUI5MnhUU2cxdmx0YkJQSm9NT1RwMkZPREJYbksyX1lLMV92bEdFLVdUYTNaRlA4a2hUOTlGNmY1TjNWNDZGbGRocFZneFp4Z1BEYkM1QTFsaERlb0tRTENkOTVDNXBVSVktTklKbW1xM1ZiRzBHU2poWXpHM3pLWlN6X2kyakZVSTFZNmotMkZTQlpWZEJjTnVsNmhSVGxmU28tQmd3eHZXZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira (NASDAQ: PCRX) divests iovera\u00b0 business to Zimmer Biomet for up to $140M", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQnpTQ2J5Uk1xcldWUEhianRIdjNCUEx5YnpPUHhZcmRocnZWY3RuSkxpc1NVbEJkdDlYZEE0MnNyNGZTWHR5TzZna0kwcWNHZlNqYnAtNG1CREFGYUhIaWd0alhSSUFKWTl0ZkZaUVdubUUzTkpfZ3VyM3ZPRTF0OUFUSE91Mzk0TE5LaFhhMEhWd3JTVDAzeENZNkc1WWx5VXJKajhyNm8wMG5Vc196ZlRR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences (NASDAQ: PCRX) SVP Finance sells shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTUJ2TGk0ZzMxZmJlNS1fLTdqSVk4QjctLU52dko2SU1OSzVtX2NHZml2RDliUFc2d2VxeWN6NEJBTEpZM1lDbzBJdmpWMkU2UDljU1I2YVhETUc0d0d6YklBZTBaUkZselRLd1ZOWmVZZzU5aUhpVnZWcllidGs1S0s4MThKN3VGSGdMY1VDaHdydnFGbk9sdEhkSkd0RXZ0eWxXR1UtM01JdWZNSkNmM2pxY01DYS15?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Three major proxy firms side with Pacira in boardroom showdown", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPQ3Q1SGg2V0NsQ2FfTXFFd0FYUXlsUUlzQ3BqX0o5U2FDZ3JaaHpMcHYzT25TdlhUNzJTSi1BaVFOVE5jVS1BNnNEbVdGTEotd25NdmtCNnJKUHZmM194dU9yckR6ZUtURUhPdWJQTUROT3dNOGFVWHdLUzVmTDlaclNmaE1fRl94TkZxb0pZeTdHX3pyMEEyMmRETUgtM1h0VlBmNHZlUWpxU1poaUZ4RDFYNkwycTl6OUt4T0VxVWo?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira Biosciences Inc (NASDAQ:PCRX) Emerges as a Deep Value Opportunity with Strong Financial Health", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOWlNZcy1QRWJKalVpekNRUk9oRFRzOW9KZ0hvZUpUQkt5T05wMGM1WFN5Z2JPR1FmRENXeU0yUGJvU0RHNDZpUHM4UDd0Q2YwNXBOeWY2X2w0TTRGLVZ3WGNnRUY3ODQ3VjZnLURhbTVTTlV0NFg5MkZjenplSzA3bDdSbkR0MXdUcFFLWkxlVzM5SFMydXlEVTJnZnBHYmhpNVplamozWXFvSV8tVzhJQlRybG5VMzl2cWdNcnFxZTY2ZEpGM3RVQk13RXpzT25MdDFSbHF6aHNkdld5UlRQeV9ndng?oc=5", "source_name": "ChartMill", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira cites 31% stock jump, $726M sales in fight with DOMA for board seats", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNaFBydmFLbHhXMG9rbW9yMkViN3BzamlZRU9MWmRER1l3TEtYTFBwMkxKU0Jrek5CcDZsUTdWVndNM2RZbkRXSnE4QkhMbVZXQl9EbkZiS0N4R21acjBJc3FOeDgyWG9kaGNWQ0dWTllqMVJtWUdRb01lcjFLVmJjZGczemJsdTQyV1pfc0tPVWpFSWlGX2tUc3dUdWo2VVpDenFXNzBZLUc1NG1aOWpLYzNEaWZQUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Considering Pacira Biosciences Inc (PCRX) Stock After Q1 Report? Check the Details", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOTG5zeHZLdV90TzJXNTVLYS03MW9lR3czWElwVXE2VmctM2JnTTViU1RiUWFTN01ieXluc2wta1M3WmtDLVA0OWhtSmVvamFscTZmb1dSSmVHOV9sQUo3ZFdROU5UbHpsRlhXdkFzdUtlWVBmdE9Fa3ptN2ZyR2Npd2JxdkZhYk1tQnd3RXd3MzB3eFl0Zm9kX2tmRG5WRGJVQUxoRHNnUkZNVE1q?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PACIRA BIOSCIENCES INC (NASDAQ:PCRX): A Value Stock Candidate with Margin of Safety", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQVWVVVmVzWjNlYUpLemoxOXFJZExsTGZ3TW52SzZMbENrUDE2bnh3RDVkRGFuWTl3UE83bmlfNW5nNVpGR2dDdkJUb0dzOWxISFl3M01KanJYYVNZOTJrSHA5YzRmTHlNSTd4Wi1jQTN0TmhtU0hsSFFuZGpzZ1pxckhtc0VxbkZHUVBJZ1BBZDVCa2tGdlJ2TmRkUk9pZ2dLYU1mYVk1a044dGJFaVVJZk9qenJXZnkwSG5ZRFVWWEVveTdCQzJueHRzQQ?oc=5", "source_name": "ChartMill", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Inc. (PCRX) Stock Rises on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOTHZQdHBMM1M1bl9JYlFhRC1rOFFHRjNNQkoxazg5TVpsSmZ5WUl4ZmtYbHBFTy1rdjViVFowVnQ3N0FGQV9jNVVsRkxXVWZlakxrc0NYMnBlWTZObE1CWmUxTHZVejhjR2hoS05obm1MUHFpVHdOeEZ5RkxDMWZ2ekw1NjVfZlJxNXYyb3FsWFVyZ2h4LVdNaWU3S3pLblNv?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQUFUTHNBOHE0bFRVTkNNSDhNQ1RzSzYwRDBQU2ZqckJ4Z1dNR3VTRkx5aU1CTHR2MFg1dWozcTJGR1lJczMwS0JmQ3BCNUFrZFE5NGpJMjNOTWtWYjREWXBaUHdERGJIUm9SNHAxMHlxS3ZBdGtubzA5aV80a3FzR0lWaVNiWlp1eWtJMnljOFE1cFRicmlrMy15NWZwZDJ3UFZJLUZWcFFUUGIzanBGaHMyYXBIazZveURNNXBEUmV4T3pzcFZtWFNOSU4tMjBURkNUbGtCWUZYbW1ubTRINXFHZ0N2dzR1THc?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira Pharmaceuticals, Inc. (PCRX) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFB1aVhXc2dOaHNLVU12dDEwSFpvUnNPV2FPTEZMQjFhS2lZUVlEYUgtODR3NFh5QUhSbHIwYk5Ra2VPdWJDT292SHkzUmdnLTdZTnNjMUVYTQ?oc=5", "source_name": "Gotrade", "published_at": "2026-01-26T20:12:21+00:00", "published_display": "26 Jan 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Working Against Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Share Price Following 28% Dive", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-17T08:00:00+00:00", "published_display": "17 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Pacira BioSciences (PCRX) Activist Pressure Amid Buybacks And Rising EXPAREL Revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOS3pmOFR3cVBtVzV3UndtWDh4cWpncDZSMXZvOVI0a0lGelhhLXJ4Xy1UY19Dd2J4Z1pRM1VwbWRFZVFLTU9jNzgzdnlEeVB2d2RvYy1KcElLVkZqSDd0d0pyVXVGcWY2Y1lhc05jZE5oUVdOOUhLNm1VSk1iS1NfMFQxQmVlNUxuaF9oQWxFSQ?oc=5", "source_name": "Market source", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxQWHVONnpNRG9ZQW9BTzFXZmRMOGt2b2F5N2c1RW1WNG1QRjZYTXB1LTFWZktHNm9HM21lWkJQR2hveDMtX1FoeldRMWJzcEdPOTRnOWUxVmdhcnBVNWpMbkFUOUZTOThKOThLSC0yYTZxc09Mc0syMHZuVlZjaGpUOWlNX09YSkdEMVVEUVhkUlpMTDFFZGZqa3JYZUczdmRrYzJ6ZS1fZEF3YUFYTVVTTWFsRVNYeUItMTJsRnFDUS01bmxKNzQ1YmpTcG1McXpFOHRJVG45ZmNFQWlxTjZjS256a1VGcTRNYTdWRExyelY3NktUY21tLWR5UW1TdldwY0Q0c3VNYVNXVFBXQ283SDY4b3FCU25FaVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences (PCRX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBGN1Y1OXY0ak1Oa053N0pmT2JOZnRBNV9UbGxCTDJXcTZDQ0FreWhTVFU2TmYxbmp3b3IxamF4MjM0dGQ0THdPQUZsVWpoZjYydzItdTZpeHNOQQ?oc=5", "source_name": "MarketBeat", "published_at": "2015-06-05T03:15:23+00:00", "published_display": "05 Jun 2015 03:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Pacira BioSciences stock trades steady as pain-management pipeline stays in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOTTVtb25fTjdNbXBvY0hIdUZBZXZUV0djTUlBazJkcXRxVU5tOGl0YndJWDlQNVlsNjNDSWplTzZ5cU9VQ1lKVkFYMlZkOWlWVTRTNGZVblowYTlIQi1LS0hPellyMXRYWVNPUTIydVQzNWJ6Q3NzYUlTejBndVp4S2UxWlYwRndBTXkxOEJkX09iejJZNWhjVjJvdERxcEJmLUlnVXlPdVY0Rl83MW1JM3ZFOU5PR3NHb1NROVkxeFdyN3piXzdOamJQYw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T14:45:35+00:00", "published_display": "09 Jul 2026 14:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences (PCRX) Wins Broader EXPAREL Reimbursement, Is The Stock Still Undervalued?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T12:40:09+00:00", "published_display": "08 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQTDZVbjY3ZV93VncyaTFFaWl5QUZfNm9MQlVya3RNV3FuRmFPRW5FSnlmbWwzbUxyYlU0VURiaFZ5OHZhNEcwQ1pIMmFpeFk0QzJsMVA3TmtadTZVR04xTXo2aDNwRXl6RTkta0hKcmJjZUktaUwyLXkzNmF2dlFlS1NxRGd1SERDejJwbXVEUXlCMVZWVjY3dzg0RmNZY2JlOFI4blF4aUtEcm9felgyaXhtZDlXRERYNVpQMFBqWE5sRGhfaDdMM1dMUDQxbWRmY3F4NQ?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-08T12:24:19+00:00", "published_display": "08 Jul 2026 12:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Pacira BioSciences (PCRX) Winning Broader EXPAREL Reimbursement From UnitedHealthcare", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T09:29:11+00:00", "published_display": "07 Jul 2026 09:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zimmer Biomet (ZBH) Is Buying Pacira\u2019s Iovera Device And Expanding Into Spasticity", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/zimmer-biomet-zbh-buying-pacira-042943339.html", "source_name": "Simply Wall St.", "published_at": "2026-07-02T04:29:43+00:00", "published_display": "02 Jul 2026 04:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences' Exparel Now Separately Reimbursed by UnitedHealthcare Across Outpatient Settings", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pacira-biosciences-apos-exparel-now-125344211.html", "source_name": "MT Newswires", "published_at": "2026-07-01T12:53:44+00:00", "published_display": "01 Jul 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL\u00ae", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pacira-biosciences-announces-unitedhealthcare-now-120000445.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T12:00:00+00:00", "published_display": "01 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zimmer Biomet to acquire iovera device from Pacira for $140m", "summary": "", "url": "https://finance.yahoo.com/m/cf358e7c-fe12-3fab-8333-794fb9d94115/zimmer-biomet-to-acquire.html", "source_name": "Medical Device Network", "published_at": "2026-07-01T10:53:42+00:00", "published_display": "01 Jul 2026 10:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealthcare opens separate reimbursement for Pacira's EXPAREL", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNaUlIYzlSdFAzcUlSNUZUS1UtTzVTOEE1VFVXNTVRWlR2dmpNQkRNNEtobm80TXhPNkFyalo0OVozNWVQekV1U3BSQ0EwYWotQzA3N3JNWTYxZU03eDFOMC1WZmdSb3pCSUJyY2hhc0Z0RXctcGZEbXpGaDdHaFMzTWw3dlVkMFhENXZYLWctSmxPTDZaY1BRR2VOWC1UZDc1MGRvRzlybGdxQk84ZWVObkpYY3FPZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Divests CryoTech to Zimmer Biomet", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPUEdRblJzUzRSMUt5YXVMNnllelV2VTJZeGs1dDhxYk5HVUNpbTA4MHg4YWQ3aVBra0tlZWxFWkh0ZjJBdWpHOVptRlRobGFKMTVHQU9ZTVVhY1B1cTZXQm80al82ZlB6V3FzZmlaSlBXakdJcFRkbU1tMlhTbkh5VXNJVnM5Z1czQ2p3MkhGTnZKU3lnTG5XRlBmN3RnZXozZC1oblo4bzQ3N2pfWDlPOEt6b01iVG5KNE52NDdjYmduZV91czFZZm53MlFsbzQwM0NZVWtn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira offloads iovera\u00b0 for up to $140M, keeps spasticity program", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOQnRzWGsxcndydGtHOUI5MnhUU2cxdmx0YkJQSm9NT1RwMkZPREJYbksyX1lLMV92bEdFLVdUYTNaRlA4a2hUOTlGNmY1TjNWNDZGbGRocFZneFp4Z1BEYkM1QTFsaERlb0tRTENkOTVDNXBVSVktTklKbW1xM1ZiRzBHU2poWXpHM3pLWlN6X2kyakZVSTFZNmotMkZTQlpWZEJjTnVsNmhSVGxmU28tQmd3eHZXZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira (NASDAQ: PCRX) divests iovera\u00b0 business to Zimmer Biomet for up to $140M", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQnpTQ2J5Uk1xcldWUEhianRIdjNCUEx5YnpPUHhZcmRocnZWY3RuSkxpc1NVbEJkdDlYZEE0MnNyNGZTWHR5TzZna0kwcWNHZlNqYnAtNG1CREFGYUhIaWd0alhSSUFKWTl0ZkZaUVdubUUzTkpfZ3VyM3ZPRTF0OUFUSE91Mzk0TE5LaFhhMEhWd3JTVDAzeENZNkc1WWx5VXJKajhyNm8wMG5Vc196ZlRR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences (NASDAQ: PCRX) SVP Finance sells shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTUJ2TGk0ZzMxZmJlNS1fLTdqSVk4QjctLU52dko2SU1OSzVtX2NHZml2RDliUFc2d2VxeWN6NEJBTEpZM1lDbzBJdmpWMkU2UDljU1I2YVhETUc0d0d6YklBZTBaUkZselRLd1ZOWmVZZzU5aUhpVnZWcllidGs1S0s4MThKN3VGSGdMY1VDaHdydnFGbk9sdEhkSkd0RXZ0eWxXR1UtM01JdWZNSkNmM2pxY01DYS15?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Three major proxy firms side with Pacira in boardroom showdown", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPQ3Q1SGg2V0NsQ2FfTXFFd0FYUXlsUUlzQ3BqX0o5U2FDZ3JaaHpMcHYzT25TdlhUNzJTSi1BaVFOVE5jVS1BNnNEbVdGTEotd25NdmtCNnJKUHZmM194dU9yckR6ZUtURUhPdWJQTUROT3dNOGFVWHdLUzVmTDlaclNmaE1fRl94TkZxb0pZeTdHX3pyMEEyMmRETUgtM1h0VlBmNHZlUWpxU1poaUZ4RDFYNkwycTl6OUt4T0VxVWo?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira Biosciences Inc (NASDAQ:PCRX) Emerges as a Deep Value Opportunity with Strong Financial Health", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOWlNZcy1QRWJKalVpekNRUk9oRFRzOW9KZ0hvZUpUQkt5T05wMGM1WFN5Z2JPR1FmRENXeU0yUGJvU0RHNDZpUHM4UDd0Q2YwNXBOeWY2X2w0TTRGLVZ3WGNnRUY3ODQ3VjZnLURhbTVTTlV0NFg5MkZjenplSzA3bDdSbkR0MXdUcFFLWkxlVzM5SFMydXlEVTJnZnBHYmhpNVplamozWXFvSV8tVzhJQlRybG5VMzl2cWdNcnFxZTY2ZEpGM3RVQk13RXpzT25MdDFSbHF6aHNkdld5UlRQeV9ndng?oc=5", "source_name": "ChartMill", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira cites 31% stock jump, $726M sales in fight with DOMA for board seats", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNaFBydmFLbHhXMG9rbW9yMkViN3BzamlZRU9MWmRER1l3TEtYTFBwMkxKU0Jrek5CcDZsUTdWVndNM2RZbkRXSnE4QkhMbVZXQl9EbkZiS0N4R21acjBJc3FOeDgyWG9kaGNWQ0dWTllqMVJtWUdRb01lcjFLVmJjZGczemJsdTQyV1pfc0tPVWpFSWlGX2tUc3dUdWo2VVpDenFXNzBZLUc1NG1aOWpLYzNEaWZQUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Considering Pacira Biosciences Inc (PCRX) Stock After Q1 Report? Check the Details", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOTG5zeHZLdV90TzJXNTVLYS03MW9lR3czWElwVXE2VmctM2JnTTViU1RiUWFTN01ieXluc2wta1M3WmtDLVA0OWhtSmVvamFscTZmb1dSSmVHOV9sQUo3ZFdROU5UbHpsRlhXdkFzdUtlWVBmdE9Fa3ptN2ZyR2Npd2JxdkZhYk1tQnd3RXd3MzB3eFl0Zm9kX2tmRG5WRGJVQUxoRHNnUkZNVE1q?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PACIRA BIOSCIENCES INC (NASDAQ:PCRX): A Value Stock Candidate with Margin of Safety", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQVWVVVmVzWjNlYUpLemoxOXFJZExsTGZ3TW52SzZMbENrUDE2bnh3RDVkRGFuWTl3UE83bmlfNW5nNVpGR2dDdkJUb0dzOWxISFl3M01KanJYYVNZOTJrSHA5YzRmTHlNSTd4Wi1jQTN0TmhtU0hsSFFuZGpzZ1pxckhtc0VxbkZHUVBJZ1BBZDVCa2tGdlJ2TmRkUk9pZ2dLYU1mYVk1a044dGJFaVVJZk9qenJXZnkwSG5ZRFVWWEVveTdCQzJueHRzQQ?oc=5", "source_name": "ChartMill", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences Inc. (PCRX) Stock Rises on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOTHZQdHBMM1M1bl9JYlFhRC1rOFFHRjNNQkoxazg5TVpsSmZ5WUl4ZmtYbHBFTy1rdjViVFowVnQ3N0FGQV9jNVVsRkxXVWZlakxrc0NYMnBlWTZObE1CWmUxTHZVejhjR2hoS05obm1MUHFpVHdOeEZ5RkxDMWZ2ekw1NjVfZlJxNXYyb3FsWFVyZ2h4LVdNaWU3S3pLblNv?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQUFUTHNBOHE0bFRVTkNNSDhNQ1RzSzYwRDBQU2ZqckJ4Z1dNR3VTRkx5aU1CTHR2MFg1dWozcTJGR1lJczMwS0JmQ3BCNUFrZFE5NGpJMjNOTWtWYjREWXBaUHdERGJIUm9SNHAxMHlxS3ZBdGtubzA5aV80a3FzR0lWaVNiWlp1eWtJMnljOFE1cFRicmlrMy15NWZwZDJ3UFZJLUZWcFFUUGIzanBGaHMyYXBIazZveURNNXBEUmV4T3pzcFZtWFNOSU4tMjBURkNUbGtCWUZYbW1ubTRINXFHZ0N2dzR1THc?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira Pharmaceuticals, Inc. (PCRX) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFB1aVhXc2dOaHNLVU12dDEwSFpvUnNPV2FPTEZMQjFhS2lZUVlEYUgtODR3NFh5QUhSbHIwYk5Ra2VPdWJDT292SHkzUmdnLTdZTnNjMUVYTQ?oc=5", "source_name": "Gotrade", "published_at": "2026-01-26T20:12:21+00:00", "published_display": "26 Jan 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Working Against Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Share Price Following 28% Dive", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQQTVMZTdYb0dZeTZlTWtLWEVja2h4d2puZXBRb1BGVHJKZF81bzMza2EzZFBjWm9kRDFRdWdnR3RCOU02M0RJQWJrd1U4aFdmRERzN2JMbDJmN3NVWmFWdExQNFFIX3B3WjNISS1DSUZtYjFEUXVGRVRTMU9fOHZHVllHOG9NeGc0VUxZQllPM1Z0SHBEZEZKYmNaaUtUUEduUTRpUG0tcE1ETlNLMS1NalQ0X0lRNDVWeERWVlRRTlB6bVVzSlU5Mnc2b2QxRjRHMnFaNmpZbU9nX3gzRDJFMTZaQXhTUdIB6wFBVV95cUxPaHFFdTVSX1gwd3BsaUhRZkszcHZkeC0ybHNKSGJrankyc3dTclBDWUIteWYwblJhRXpsSHhiM3ZGRWVGOVduTnRPWEROM3p3NGVIUUFOYW9TUE1kRVpzSVhqRzVQZERkZnJGTmk5RTNzcTlGVUFKLWZNREpPeXZ3TERjbmpnaURtUHZIeUV5UHdRNVlLYTg2V1ZSS0kxOEJvX3RUR1dPU2gtb1RGVVBKT25MMWROWWFHR29XUlprOUhYRzdzdUlGd1o2dFNOTWF4QlJYaGxhaFJ2M2RHdVR4dXljZWFsQWpjQ180?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-17T08:00:00+00:00", "published_display": "17 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Pacira BioSciences (PCRX) Activist Pressure Amid Buybacks And Rising EXPAREL Revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOS3pmOFR3cVBtVzV3UndtWDh4cWpncDZSMXZvOVI0a0lGelhhLXJ4Xy1UY19Dd2J4Z1pRM1VwbWRFZVFLTU9jNzgzdnlEeVB2d2RvYy1KcElLVkZqSDd0d0pyVXVGcWY2Y1lhc05jZE5oUVdOOUhLNm1VSk1iS1NfMFQxQmVlNUxuaF9oQWxFSQ?oc=5", "source_name": "Market source", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxQWHVONnpNRG9ZQW9BTzFXZmRMOGt2b2F5N2c1RW1WNG1QRjZYTXB1LTFWZktHNm9HM21lWkJQR2hveDMtX1FoeldRMWJzcEdPOTRnOWUxVmdhcnBVNWpMbkFUOUZTOThKOThLSC0yYTZxc09Mc0syMHZuVlZjaGpUOWlNX09YSkdEMVVEUVhkUlpMTDFFZGZqa3JYZUczdmRrYzJ6ZS1fZEF3YUFYTVVTTWFsRVNYeUItMTJsRnFDUS01bmxKNzQ1YmpTcG1McXpFOHRJVG45ZmNFQWlxTjZjS256a1VGcTRNYTdWRExyelY3NktUY21tLWR5UW1TdldwY0Q0c3VNYVNXVFBXQ283SDY4b3FCU25FaVE?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacira BioSciences (PCRX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBGN1Y1OXY0ak1Oa053N0pmT2JOZnRBNV9UbGxCTDJXcTZDQ0FreWhTVFU2TmYxbmp3b3IxamF4MjM0dGQ0THdPQUZsVWpoZjYydzItdTZpeHNOQQ?oc=5", "source_name": "MarketBeat", "published_at": "2015-06-05T03:15:23+00:00", "published_display": "05 Jun 2015 03:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 58, "total_relevant": 25, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 24, "score": 51, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 12.1, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 25.48, "latest_week": "2026-07-10", "one_week_move": 0.4, "four_week_move": 10.8, "twelve_week_move": 3.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.506579, "market_dynamics_buy_signal": false, "relative_strength": -7.606454, "fair_value_gap": 2.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 37.9443, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.4% over one week, +10.8% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 6}, {"label": "simplywall.st", "count": 3}, {"label": "ChartMill", "count": 2}, {"label": "Market source", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "Ad-hoc-news.de", "count": 1}, {"label": "markets.businessinsider.com", "count": 1}, {"label": "Simply Wall St.", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.4% over one week, +10.8% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Pacira BioSciences stock trades steady as pain-management pipeline stays in focus"}], "updated_at": "2026-07-16T00:49:41.469459+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}